IGC Pharma, Inc.IGCNYSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank53
3Y CAGR-16.4%
5Y CAGR-9.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-16.4%/yr
vs +22.6%/yr prior
5Y CAGR
-9.0%/yr
Recent deceleration
Acceleration
-39.0pp
Decelerating
Percentile
P53
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$4.64M+5.2%
2025$4.41M-34.7%
2024$6.76M-15.0%
2023$7.95M-40.2%
2022$13.29M+78.5%
2021$7.45M+24.8%
2020$5.97M+69.6%
2019$3.52M+88.2%
2018$1.87M-17.7%
2017$2.27M-